MedinCell S.A. (MDCLF)
USD 6.98
(-0.06%)
USD 6.98
(-0.06%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 44.66 Million EUR | -22.91% |
| 2023 | 51.24 Million EUR | 124.0% |
| 2022 | 22.87 Million EUR | 710.0% |
| 2021 | -3.75 Million EUR | -117.47% |
| 2020 | 21.46 Million EUR | 273.17% |
| 2019 | 5.75 Million EUR | -74.1% |
| 2018 | 22.2 Million EUR | 31.54% |
| 2017 | 16.88 Million EUR | 357.98% |
| 2016 | 3.68 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 38.64 Million EUR | -24.59% |
| 2024 Q2 | 51.54 Million EUR | 33.39% |
| 2024 Q3 | 44.6 Million EUR | -13.46% |
| 2024 Q4 | 44.66 Million EUR | -11.44% |
| 2024 FY | 44.66 Million EUR | -12.84% |
| 2023 Q4 | 51.24 Million EUR | 1.27% |
| 2023 Q1 | 36.1 Million EUR | 57.84% |
| 2023 Q2 | 36.73 Million EUR | 1.74% |
| 2023 Q3 | 50.59 Million EUR | 37.73% |
| 2023 FY | 51.24 Million EUR | 124.0% |
| 2022 Q2 | 10.7 Million EUR | 4.26% |
| 2022 FY | 22.87 Million EUR | 710.0% |
| 2022 Q4 | 22.87 Million EUR | 2.61% |
| 2022 Q3 | 22.29 Million EUR | 108.33% |
| 2022 Q1 | 10.26 Million EUR | 373.71% |
| 2021 Q1 | 16.25 Million EUR | -24.28% |
| 2021 FY | -3.75 Million EUR | -117.47% |
| 2021 Q4 | -3.75 Million EUR | 9.42% |
| 2021 Q3 | -4.14 Million EUR | -125.01% |
| 2021 Q2 | 16.55 Million EUR | 1.88% |
| 2020 FY | 21.46 Million EUR | 273.17% |
| 2020 Q4 | 21.46 Million EUR | 1.53% |
| 2020 Q3 | 21.13 Million EUR | 24.94% |
| 2020 Q2 | 16.91 Million EUR | 1.09% |
| 2020 Q1 | 16.73 Million EUR | 190.99% |
| 2019 FY | 5.75 Million EUR | -74.1% |
| 2019 Q4 | 5.75 Million EUR | 1.0% |
| 2019 Q2 | 32.62 Million EUR | 0.18% |
| 2019 Q3 | 5.69 Million EUR | -82.55% |
| 2019 Q1 | 32.56 Million EUR | 46.65% |
| 2018 Q3 | 22.16 Million EUR | 0.0% |
| 2018 Q4 | 22.2 Million EUR | 0.21% |
| 2018 FY | 22.2 Million EUR | 31.54% |
| 2018 Q1 | 9.28 Million EUR | 0.0% |
| 2017 FY | 16.88 Million EUR | 357.98% |
| 2016 FY | 3.68 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 42.79 Million USD | -4.363% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -7075.865% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | -2.823% |
| Adynxx, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | -1310.00 USD | 3409260.305% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 17991.195% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 218935.751% |
| Qrons Inc. | 351.42 Thousand USD | -12608.187% |
| Rebus Holdings, Inc. | 305 Thousand USD | -14542.623% |
| Skye Bioscience, Inc. | -5.72 Million USD | 880.58% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 808.38% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -224694.886% |
| Arch Therapeutics, Inc. | 5.64 Million USD | -690.671% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | -183.322% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | -984.501% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -11013.627% |
| SQZ Biotechnologies Company | -36.23 Million USD | 223.241% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | -1891.764% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -4716.725% |
| Mesoblast Limited | 55.85 Million USD | 20.048% |
| Marizyme, Inc. | 18.56 Million USD | -140.508% |
| Genus plc | 190.6 Million USD | 76.569% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | -1897.467% |
| Pharming Group N.V. | 109.8 Million USD | 59.328% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -5091.568% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -3579.087% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -6467.647% |
| ContraFect Corporation | -6.02 Million USD | 841.122% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -33070.181% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -3765.231% |
| IMV Inc. | 7.67 Million USD | -482.229% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | -711.72% |
| MultiCell Technologies, Inc. | 90.04 USD | -49600077.699% |
| ONE Bio Corp. | 9.04 Million USD | -394.025% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 6184.651% |
| RVL Pharmaceuticals plc | 12.94 Million USD | -244.971% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | -3164.689% |
| Q BioMed Inc. | 4.06 Million USD | -999.998% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | -46.167% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -4331.804% |
| Biomind Labs Inc. | 711.4 Thousand USD | -6177.745% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 26.238% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | -2133.679% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | -248.727% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -12315.557% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -31844.723% |
| Curative Biotechnology, Inc. | 2.2 Million USD | -1928.174% |
| GB Sciences, Inc. | 1.74 Million USD | -2455.92% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 24399.737% |
| HST Global, Inc. | 96.79 Thousand USD | -46039.7% |
| CSL Limited | 10.52 Billion USD | 99.576% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -21556.798% |
| Halberd Corporation | 144.72 Thousand USD | -30759.378% |
| Enzolytics Inc. | 981.65 Thousand USD | -4449.455% |
| Agentix Corp. | 37.63 Thousand USD | -118578.749% |
| Resverlogix Corp. | 6.45 Million USD | -592.296% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 6735.081% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 102.201% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 194.997% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -531.596% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -1548.813% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 605.209% |
| AVAX Technologies, Inc. | -5.9 Million USD | 856.538% |
| Zenith Capital Corp. | 10.06 Thousand USD | -443659.936% |
| Genscript Biotech Corporation | -1.06 Billion USD | 104.208% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -22181.871% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | -1771.725% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -27047.451% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 243903.909% |
| Kadimastem Ltd | -253.1 Thousand USD | 17745.06% |
| Helix BioMedix, Inc. | -2.57 Million USD | 1837.722% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | -120.26% |
| BioStem Technologies, Inc. | 4.47 Million USD | -898.656% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -22090.863% |
| LadRx Corporation | -2.03 Million USD | 2293.012% |
| Cell Source, Inc. | 9.23 Million USD | -383.754% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -6931.222% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -6931.222% |
| NovAccess Global Inc. | 2.17 Million USD | -1950.067% |
| Affymax, Inc. | -5.59 Million USD | 897.927% |
| Itoco Inc. | 228.3 Thousand USD | -19461.551% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -32740.892% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | -800.948% |
| Mobile Lads Corp. | 484.23 Thousand USD | -9122.852% |
| CytoDyn Inc. | 20.26 Million USD | -120.413% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 6902727.512% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 481955.435% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | -479.548% |
| SYBLEU INC | 473.71 Thousand USD | -9327.629% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | -902.014% |
| International Stem Cell Corporation | 2.59 Million USD | -1624.324% |
| Bioxytran, Inc. | 1.89 Million USD | -2251.871% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -71455.605% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -1947.778% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | -1200.524% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | -422.156% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -5680.429% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 3672.8% |
| Neutra Corp. | 52.18 Thousand USD | -85476.868% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 1894.295% |
| PureTech Health plc | -167.19 Million USD | 126.711% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 18335.419% |
| IXICO plc | -4.44 Million USD | 1104.818% |
| IntelGenx Technologies Corp. | 13.21 Million USD | -237.847% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 18.579% |
| CSL Limited | 10.52 Billion USD | 99.576% |
| Cellectis S.A. | -43.81 Million USD | 201.92% |